Dandara Baia Bonifácio

Mrs. Dandara Baia Bonifácio

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GFGabriela Macedo Fraiz
Gabriela Macedo Fraiz
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
ULUdielle Vermelho Lacerda
Udielle Vermelho Lacerda
RCRodrigo REzende Cardoso
Rodrigo REzende Cardoso
Viviana CorichViviana Corich
Viviana Corich
JBJosefina Bressan
Josefina Bressan
Background: Green tea kombucha (GTK) is a fermented beverage with promising health benefits, but few studies proved its impact on human health. Thus, we aimed to investigate the impact of GTK on weight loss, inflammation, and salivary microbiota in individuals with excess body weight. Methods: This is a randomized controlled clinical trial that lasted 10 weeks with two groups of individuals with excess body weight: control (CG; n = 29; caloric restriction) and kombucha (KG; n = 30; caloric restriction + 200 mL GTK). Body composition, anthropometry, saliva, and blood collection were performed in the beginning and end of the intervention. Plasma interleukins were determined by flow cytometry. Salivary microbiota was analyzed by 16S rRNA sequencing. Results: Both groups decreased weight, BMI, and body fat (p < 0.001) after the intervention, but there were no differences between groups. The KG reduced lipid accumulation product (LAP) (p = 0.029). Both groups decreased IL-1β and IL-8, but IL-6 increased in the CG (p = 0.023) compared to the kombucha group. Alpha and beta diversity of salivary microbiota increased in the KG. Moreover, the KG presented lower Bacillota/Bacteroidota ratio (p = 0.028), and BMI was positively associated with the Bacillota phylum. Conclusions: GTK did not enhance weight loss, but it decreased the LAP. GTK helped in the inflammatory profile and induced positive changes in oral microbiota composition.

14 November 2024 in Foods
Verified
Journal Article
Open access
PDF file
GFGabriela Macedo Fraiz
Gabriela Macedo Fraiz
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
ULUdielle Vermelho Lacerda
Udielle Vermelho Lacerda
RCRodrigo REzende Cardoso
Rodrigo REzende Cardoso
Viviana CorichViviana Corich
Viviana Corich
JBJosefina Bressan
Josefina Bressan
Green tea kombucha (GTK) has emerged as a promising probiotic fermented beverage. Few studies have investigated its effect on human health, mainly focusing on intestinal health, microbiota composition, and metabolomics. The present study is a pioneer in investigating the effect of GTK consumption in individuals with excess body weight. This is a randomized controlled trial, lasting ten weeks, with two groups placed under an energy-restricted diet: control (CG, n = 29), kombucha (KG, n = 30; 200 mL/d). Biological samples and questionnaires were collected before and after the intervention. Microbiota analysis used an amplification of the V4 region of 16S rRNA. Serum untargeted metabolomics used HPLC-TOF mass spectrometry. Intestinal permeability considered the urine excretion of lactulose and mannitol, plasma zonulin, and LPS-binding protein. After the intervention, no differences related to intestinal permeability and microbiota were found between groups, but only the CG had increased fecal pH, lactulose/mannitol ratio, and zonulin. In addition to this, the KG reported lower gastrointestinal symptoms related to motility compared to the CG, and discriminant metabolites (e.g., diethyl malonate) were found strictly in the KG. GTK did not significantly improve gut microbiota and intestinal permeability. However, GTK ameliorated gastrointestinal symptoms and positively influenced the serum metabolome, which may contribute to enhancing the metabolic health of individuals with excess body weight.

17 June 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
GFGabriela Macedo Fraiz
Gabriela Macedo Fraiz
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
RPRayanne Santos de Paulo
Rayanne Santos de Paulo
CTCarolynne Teixeira
Carolynne Teixeira
HMHercia Martino
Hercia Martino
JBJosefina Bressan
Josefina Bressan
Background: Fermented foods rich in bioactive compounds have been proposed as potential strategy to combat non-communicable diseases. Among them is kombucha, a beverage fermented from sugared Camellia sinensis tea by a symbiotic culture of bacteria and yeasts (SCOBY). Recently, there has been an increased focus on assessing the actual effect of this beverage on human health. In this manner, this systematic review aimed to gather clinical evidence on the impact of kombucha consumption on human health. Methods: The databases Cochrane CENTRAL, MEDLINE/PubMed, and Embase® were searched, and the risk of bias tool used was the Critical Appraisal Tools outlined in the Joanna Briggs Institute. This review followed the PRISMA guidelines and was registered on PROSPERO (CRD42024599464). Results: Eight clinical trials were included (two pre- and post-interventions and six randomized controlled trials) with durations ranging from 10 days to 10 weeks. Two studies reported beneficial effects of kombucha on gastrointestinal symptoms, such as reduced intensity of constipation-related complaints. Two trials observed changes in gut microbiota composition, including increased abundance in Bacteroidota, Akkermansiaceae, Saccharomyces, and Weizmannia coagulans, alongside reductions in Ruminococcus, Dorea, and Rhodotorula. Moreover, five clinical trials evaluated glucose metabolism, evidencing inconsistent results, and other studies identified improvements in salivary microbiota composition and serum metabolomic profile. Conclusion: These findings suggest that kombucha consumption may provide health benefits, particularly in alleviating gastrointestinal symptoms, and demonstrates a modest capacity for modulating gut and salivary microbiota, as well as metabolomic profiles. Although the results are promising, the heterogeneity of the studies and the limited number of available clinical trials highlight the need for further robust research to confirm these effects.

1 October 2023 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
ACAna Paula Silva Caldas
Ana Paula Silva Caldas
MCMirian Aparecida de Campos Costa
Mirian Aparecida de Campos Costa
DRDaniela Mayumi Usuda Prado Rocha
Daniela Mayumi Usuda Prado Rocha
HHHelen Hermana Miranda Hermsdorff
Helen Hermana Miranda Hermsdorff
JBJosefina Bressan
Josefina Bressan
Nuts are important sources of antioxidants that combat oxidative stress and improve lipid profile as well as vascular function. However, the intake of typical Brazilian nuts and its acute effect on cardiovascular health needs to be better understood. Thus, the present study aimed to evaluate the acute effect of a beverage containing cashew ( Anacardium occidentale L.) and Brazil nuts ( Bertholletia excelsa H.B.K.) on postprandial oxidative stress, lipemia, and blood pressure of adult women aged 20 to 55 years with cardiometabolic risk. This was an acute, randomized, parallel arm, controlled clinical trial. The participants received either a beverage containing nuts (30 g Brazil nuts + 15 g cashew nuts) or a beverage without nuts with similar macronutrient composition. Oxidative stress markers and lipid profiles were evaluated at fasting and 4 h after beverage consumption. Blood pressure was measured during fasting and after beverage intake (1, 2, 3, and 4 h). In the postprandial state, there was a greater reduction in malondialdehyde levels in the intervention group compared to the control group (−12.3 ± 0.59 vs. −10.7 ± 0.43 µmol/mL; p < 0.05), which was positively correlated with the concentrations of TG ( r = 0.399; p < 0.05), VLDL ( r = 0.399; p < 0.05), TG/HDL ( r = 0.380; p < 0.05), and blood pressure (iAUC SBP r = 0.391; p < 0.05, iAUC DBP r = 0.409; p < 0.05). The remaining oxidative stress markers showed similar postprandial changes between groups. In women with cardiometabolic risk, a beverage containing Brazilian nuts promoted a significant acute reduction on postprandial malondialdehyde levels. The study was registered in the Brazilian Clinical Trials Registry—ReBEC (protocol: RBR-3ntxrm).

10 July 2025 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
GFGabriela Macedo Fraiz
Gabriela Macedo Fraiz
ULUdielle Vermelho Lacerda
Udielle Vermelho Lacerda
RCRodrigo Rezende Cardoso
Rodrigo Rezende Cardoso
AKAna Claudia Pelissari Kravchychyn
Ana Claudia Pelissari Kravchychyn
JBJosefina Bressan
Josefina Bressan
Kombucha is a fermented beverage rich in bioactive compounds. This beverage has demonstrated high antioxidant capacity in vitro and experimental animal studies. In this sense, this study aimed to evaluate the effect of daily consumption of green tea kombucha on oxidative stress and endothelial health in individuals with excess body weight. This is a randomized controlled clinical trial, lasting 10 weeks, during which the control group followed a healthy −500 kcal/d energy-restricted diet. In contrast, the kombucha group, in addition to the energy-restricted diet, consumed 200 ml of kombucha green tea daily. This study included men and women aged 18–45 years without chronic diseases. At the beginning and end of the study, fasting blood was collected, and colorimetric assays and immunoassay protocols evaluated markers of oxidative stress and endothelial health. Compared to the control group, kombucha consumption significantly reduced hydrogen peroxide (H2O2) levels (P = 0·007). Initial and final values were as follows: Control group (16·5 v. 15·09 µmol/ml; n 29) and Kombucha group (18·14 v. 14·67 µmol/ml; n 30). The other markers that were evaluated did not change after the kombucha consumption. In conclusion, daily consumption of 200 ml of green tea kombucha for 10 weeks reduces one pro-oxidant marker, without altering other markers of oxidative stress and endothelial health in individuals with excess body weight. Reducing a pro-oxidant marker suggests that kombucha is an antioxidant beverage with promising implications for human health. However, further studies are needed to elucidate other possible beneficial effects on health.

9 November 2023 in Food Reviews International
Verified
Journal Article
Closed access
DBDandara Baia Bonifácio
Dandara Baia Bonifácio
LVLeonara Martins Viana
Leonara Martins Viana
ASAlessandra Silva
Alessandra Silva
DGDanúbia Joanes Rosa Guerra
Danúbia Joanes Rosa Guerra
CSCaroline Woelffel Silva
Caroline Woelffel Silva
JBJosefina Bressan
Josefina Bressan